Approval · Notice of Compliance 24314 · 2020
EYLEA: Notice of Compliance 24314
Issued September 25, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24314
- Date
- September 25, 2020
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New presentation and new drug product manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EYLEA | 02505355 | Marketed |
Medicinal ingredients
- AFLIBERCEPT 40 MG per ML